2010
DOI: 10.1002/ccd.22437
|View full text |Cite
|
Sign up to set email alerts
|

Rotational atherectomy for fibro‐calcific coronary artery disease in drug eluting stent era: Procedural outcomes and angiographic follow‐up results

Abstract: Rotational atherectomy can be performed with high success rates and low complications, and rotational atherectomy followed by drug eluting stent implantation significantly reduces binary restenosis rates in fibrocalcific lesions as compared to rotational atherectomy and bare metal stents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

9
75
1
2

Year Published

2010
2010
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 84 publications
(87 citation statements)
references
References 46 publications
(54 reference statements)
9
75
1
2
Order By: Relevance
“…On the other hand, we have also proven that long‐term FU of our high‐risk, elderly RA stented patients yield acceptable all‐cause mortality data as compared with that in other databases 1, 2, 3, 4, 5, 6.…”
Section: Discussionmentioning
confidence: 51%
See 3 more Smart Citations
“…On the other hand, we have also proven that long‐term FU of our high‐risk, elderly RA stented patients yield acceptable all‐cause mortality data as compared with that in other databases 1, 2, 3, 4, 5, 6.…”
Section: Discussionmentioning
confidence: 51%
“…Rathore et al 5 compared the restenosis, success rate, and the in‐hospital outcomes after RA with BMS versus DES implantations and have found significantly better restenosis rates following DES implantation (11% vs. 28.1%, P  < 0.001). Benezet et al 1 published total cardiac death, target lesion revascularization, and MI incidence rates of up to 4.9%, 3.9%, and 8.8%, respectively, at 15 months FU with RA stenting using DES devices.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Recently published intermediate and long-term outcomes after PCI and DES with adjunctive RA report rates of target lesion revascularisation (TLR) < 10% within one to two years [6]. In patients treated with RA, rates of MACE are lower with DES stenting compared with bare-metal stent (BMS) stenting [6,7]. However, the ROTAXUS study did not demonstrate the advantage of RA with DES implantation over angioplasty with DES alone [8].…”
Section: Next Year Will Mark the 30mentioning
confidence: 99%